Glu298Asp endothelial nitric oxide synthase polymorphism is a risk factor for erectile dysfunction in the Mexican mestizo population

Journal of Andrology

Volumn 25, Issue 5, 2004, Pages 728-732

  Rosas Vargas, Haydee ^a   Coral Vazquez, Ramon M ^a   Tapia, Rosario ^b   Borja, Jose L ^a   Salas, Ricardo A ^b   Salamanca, Fabio ^a  

^a HOSPITAL DE PEDIATRÍA   (Mexico)

^b HOSPITAL DE ESPECIALIDADES   (Mexico)

Author keywords

Angiotensin converting enzyme; Endothelial dysfunction; Impotence

Indexed keywords

ANGIOTENSIN; ASPARTIC ACID; DIPEPTIDYL CARBOXYPEPTIDASE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GLUTAMIC ACID; GUANOSINE PHOSPHATE; NITRIC OXIDE;

ADULT; ALLELE; ARTICLE; BLOOD VESSEL TONE; CHEMICAL INTERACTION; CIGARETTE SMOKING; CONTROLLED STUDY; DIABETES MELLITUS; ENZYME POLYMORPHISM; ERECTILE DYSFUNCTION; GENETIC SUSCEPTIBILITY; GENOTYPE; HEART DISEASE; HETEROZYGOTE; HISPANIC; HUMAN; HYPERTENSION; IMPOTENCE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PENIS ERECTION; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RISK FACTOR; SMOOTH MUSCLE TONE;

EID: 4143075936     PISSN: 01963635     EISSN: None     Source Type: Journal    
DOI: 10.1002/j.1939-4640.2004.tb02847.x     Document Type: Article

References (37)

1. Alderton WK, Cooper CE, Knowles RG. Nitric oxide synthases: structure, function and inhibition. Biochem J. 2001;357:593-615.
2. Andersson KE. Pharmacology of penile erection. Pharmacol Rev. 2001; 53:417-450.
3. Becker AJ, Uckert S, Stief CG, et al. Possible role of bradykinin and angiotensin II in the regulation of penile erection and detumescence. Urology. 2001;57:193-198.
4. Bivalacqua TJ, Champion HC, Mehta YS, Abdel-Mageed AB, Sikka SC, Ignarro LJ, Kadowitz PJ, Hellstrom WJ. Adenoviral gene transfer of endothelial nitric oxide synthase (eNOS) to the penis improves age-related erectile dysfunction in the rat. Int J Impot Res. 2000;12:S8-17.
5. Bivalacqua TJ, Usta MF, Champion HC, Adams D, Namara DB, Abdel-Mageed AB, Kadowitz PJ, Hellstrom WJ. Gene transfer of endothelial nitric oxide synthase partially restores nitric oxide synthesis and erectile function in streptozotocin diabetic rats. J Urol. 2003;169:1911-1917.
6. Bloch W, Klotz T, Sedlaczek P, Zumbe J, Engelmann U, Addicks K. Evidence for the involvement of endothelial nitric oxide synthase from smooth muscle cells in the erectile function of the human corpus cavernosum. Urol Res. 1998;26:129-135.
7. Cambien F, Poirier O, Lecerf L, et al. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature, 1992;359:641-644.
8. Eisenhardt A, Sperling H, Hauck E, Porst H, Stief C, Rubben H, Muller N, Siffert W. ACE gene I/D and NOS3 G894T polymorphisms and response to sildenafil in men with erectile dysfunction. Urology. 2003; 62:152-157.
9. Fairchild TA, Fulton D, Fontana JT, Gratton JP, McCabe TJ, Sessa WC. Acidic hydrolysis as a mechanism for the cleavage of the Glu198Asp variant of human endothelial nitric oxide synthase. J Biol Chem. 2001; 276:26674-26679.
10. Gonzalez-Cadavid NF, Rajfer J. Therapeutic stimulation of penile nitric oxide synthase (NOS) and related pathways. Drugs Today (Barc). 2000;36:163-174.
11. Hingorani AD, Liang CF, Fatibene J, et al. A common variant of the endothelial nitric oxide synthase (Glu298Asp) is a major risk factor for coronary disease in the UK. Circulation. 1999;100:1515-1520.
12. Jachymova M, Horky K, Bultas J, Kozich V, Jindra A, Peleska J, Martasek P. Association of the Glu298Asp polymorphism in the endothelial nitric oxide synthase gene with essential hypertension resistant to conventional therapy. Biochem Biophys Res Comm. 2001;284:426-430.
13. Kempter B, Grossbadern K. Quick preparation of high molecular weight DNA by freezing. Trends Genet. 1992;8:226.
14. Kim DS, Choi SI, Lee HS, Park JK, Yi HI. Determination of human angiotensin converting enzyme (ACE) gene polymorphism in erectile dysfunction: frequency differences of ACE gene polymorphisms according to the method of analysis. Clin Chem Lab Med. 2001;39:11-14.
15. Klotz T, Mathers MJ, Braun M, Bloch W, Engelmann U. Effectiveness of oral L-arginine in first-line treatment of erectile dysfunction in a controlled crossover study. Urol Int. 1999;63:220-223.
16. Liao YL, Saku K, Ou J. A missense mutation of the nitric oxide synthase (eNOS) gene (Glu298Asp) in five patients with coronary artery disease: case reports. Angiology. 1999;50:671-676.
17. Lindpaintner K, Pfeffer MA, Kreutz R, Stampfer MJ, Grodstein F, LaMotte F, Buring J, Hennekens CH. A prospective evaluation of an angiotensin- converting-enzyme gene polymorphism and the risk of ischemic heart disease. New Engl J Med. 1995;332:706-711.
18. Marre M, Jeunemaitre X, Gallois Y, et al. Contribution of genetic polymorphism in the renin-angiotensin system to the development of renal complications in insulin-dependent diabetes: Genetique de la Nephropathie Diabetique (GENEDIAB) Study Group. J Clin Invest. 1997; 99:1585-1595.
19. Miller TA. Diagnostic evaluation of erectile dysfunction. Am Fam Physician. 2000;61:95-104.
20. Montgomery HE, Clarkson P, Dollery CM, et al. Association of angiotensin-converting enzyme gene I/D polymorphism with change in left ventricular mass in response to physical training. Circulation. 1997; 96:741-747.
21. Nakayama T, Soma M, Takahashi Y, Izumi Y, Kanmatsuse K, Esumi M. Association analysis of CA repeat polymorphism of the endothelial nitric oxide synthase gene with essential hypertension in Japanese. Clin Genet. 1997;51:26-30.
22. Rajfer J, Aronson WJ, Bush PA, Dorey FJ, Ignarro LJ. Nitric oxide as the mediator of relaxation of the courpus cavernosum in response to nonadrenergic, noncolinergic neurotransmission. N Engl J Med. 1992; 326:90-94.
23. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest. 1990;86:1343-1346.
24. Rigat B, Hubert C, Corvol P, Soubrier F. PCR detection of the insertion/ deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase 1). Nucleic Acids Res. 1992;20:1433.
25. Roks AJ, van Geel PP, Pinto YM, Buikema H, Henning RH, de Zeeuw D, van Gilst WH. Angiotensin-(1-7) is a modulator of the human renin-angiotensin system. Hypertension. 1999;34:296-301.
26. Rosas-Vargas H, Flores-Segura A, Guizada-Claure B, Vargas-Alarcon G, Granados J, Salamanca F, Coral-Vazquez R. Endothelial nitric oxide synthase gene polymorphism in the Indian and Mestizo populations of Mexico. Hum Biol. 2003;75:91-96.
27. Shabsigh R, Anastasiadis AG. Erectile dysfunction. Annu Rev Med. 2003; 54:153-168.
28. Shimasaki Y, Yasue H, Yoshimura M, et al. Association of the missense Glu298Asp variant of the endothelial nitric oxide synthase gene with myocardial infarction. J Am Coll Cardiol. 1998;31:1506-1510.
29. Shoji M, Tsutaya S, Saito R, Takamatu H, Yasujima M. Positive association of endothelial nitric oxide synthase gene polymorphism with hypertension in northern Japan. Life Sci. 2000;66:2557-2562.
30. Tesauro M, Thompson WC, Rogliani P, Qi L, Chaudhary PP, Moss J. Intracellular processing of endothelial nitric oxide synthase isoforms associated with differences in severity of cardiopulmonary diseases: cleavage of proteins with aspartate vs. glutamate at position 298. Proc Natl Acad Sci U S A. 2000;97:2832-2835.
31. Turner AJ, Hooper NM. The angiotensin-converting enzyme gene family: genomics and pharmacology. Trends Pharmacol Sci. 2002;23:177-183.
32. Unkelbach M, Auch-Schwelk W, Unkelbach E, Jautzke G, Fleck E. Regulation of aortic wall structure by the renin-angiotensin system in Wistar rats. J Cardiovasc Pharmacol. 1998;31:31-38.
33. Villard E, Soubrier F. Molecular biology and genetics of the angiotensin-I-converting enzyme: potential implications in cardiovascular diseases. Cardiovasc Res. 1996;32:999-1007.
34. Wang XL, Sim AS, Badenhop RF, McCredie RM, Wilcken DE. A smoking-dependent risk of coronary artery disease associated with a polymorphism of the endothelial nitric oxide synthase gene. Nature Med. 1996;2:41-45.
35. Yan C, Kim D, Aizawa T, Berk BC. Functional interplay between angiotensin II and nitric oxide. Arterioscler Thromb Vasc Biol. 2003;23: 26-36.
36. Yoshida H, Mitarai T, Kawamura T, et al. Role of the deletion of polymorphism of the angiotensin converting enzyme gene in the progression and therapeutic responsiveness of IgA nephropathy. J Clin Invest. 1995;96:2162-2169.
37. Yoshimura M, Yasue H, Nakayama M, et al. A missense Glu298Asp variant in the endothelial nitric oxide synthase gene is associated with coronary spasm in the Japanese. Hum Genet. 1998;103:65-69.